Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)
NCT ID: NCT04673227
Last Updated: 2020-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2020-01-02
2022-12-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Contact with active TB/ LTBI
After a close contact with bacteriologically confirmed TB suspicion for LTBI with an evidence of previous BCG vaccination status TB confirmed with TST (TST ≥ 5 mm or BCG unvaccinated or TST ≥ 15 mm for BCG vaccinated) 20 children and adolescents 20 adults
Blood draw
Blood draw and the analysis of blood in laboratory
Active TB group
Active TB group with positive microbial culture and pathological chest radiography or chest CT 20 children and adolescents 20 adults
Blood draw
Blood draw and the analysis of blood in laboratory
Contact with active TB/ negative
After a close contact with bacteriologically confirmed TB no evidence of TB in TST or IGRA test for 3 months 20 children and adolescents 20 adults
Blood draw
Blood draw and the analysis of blood in laboratory
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood draw
Blood draw and the analysis of blood in laboratory
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
4 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charles University, Czech Republic
OTHER
Thomayer University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karolína Doležalová, M.D.
M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Science
Prague, , Czechia
Thomayer Hospital
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Petra Hadlová, Mgr.
Role: primary
Karel Drbal, Doc.
Role: backup
Karolína Doležalová, MD
Role: primary
Martina Vašáková, Prof
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ThomayerH
Identifier Type: -
Identifier Source: org_study_id